Enzastaurin for Patients With Metastatic Colorectal Cancer

Clinical trial NCT00192114 · COMPLETED

Trial details

NCT number: NCT00192114
Sponsor: Eli Lilly and Company
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Colonic Neoplasms

Start date: 2005-08-01
Primary completion: 2008-03-01
Enrollment: 28

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.